Ajanta Pharma (AJANTPHARM) — Announcement

📢 Key Event
Ajanta Pharma schedules investor meetings for September 16 and 28, 2026

💡 Investor Takeaway
Investors should monitor these meetings for potential valuation cues and management commentary on growth prospects.

Ajanta Pharma announced its schedule for upcoming investor meetings with Jefferies India Forum on September 16, 2026, and PL Capital Mid & Small Cap Conference on September 28, 2026, both in Mumbai. These one-on-one and group sessions will focus exclusively on previously published company information, with no new financial data expected. The filing underscores the company's active engagement with institutional investors ahead of potential valuation discussions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Ltd (AJANTPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹44,226.59 Cr P/E: 39.0 ROE: 25.1% ROCE: 31.8% Div Yield: 0.79%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"When will the next earnings release occur?" "What is the company's revenue growth target for FY27?" "How does Ajanta's margin compare to peers like Sun Pharma?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 31 August 2026

526159 Nikhil Adhesives Ltd Annual Report VIDHIING Vidhi Specialty Food Ingredients Ltd Annual Report 544855 Prima Innovation Ltd Annual Report TICL Twamev Construction & Infrastructure Ltd Annual Report TICL Twamev Construction & Infrastructure Ltd Annual Report TI Tilaknagar Industries Ltd Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd